rheumatology
JIA

Genomic tests will help early diagnosis and targeted treatment of JIA

A new genomic risk score (GRS) for juvenile idiopathic arthritis (JIA) has the potential to help children with pain get faster access to the right treatments, rheumatologists have shown. An international group of researchers led by Australians developed an overall JIA GRS using machine learning in a large UK cohort of cases and controls and ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic